Salah Nabhan

Salah Nabhan currently serves as the Senior Director of Clinical Operations at MOMA Therapeutics, a position held since July 2023. Prior to this, Salah held key roles in clinical operations at Foghorn Therapeutics, Inc. and Silicon Therapeutics, Inc. as Director of Clinical Operations. Salah's extensive experience includes significant positions at Agios Pharmaceuticals, where roles encompassed Associate Director of Clinical Operations (Early Oncology Development), Senior Clinical Trial Manager, and Clinical Trial Manager, along with leadership as a Lead Clinical Trial Specialist at Sarah Cannon Research Institute. Salah began a career in clinical research as a Clinical Trial Specialist at the University of Arkansas, after obtaining a Master of Science in Molecular Genetics and Pharmacology and a Bachelor of Science in Biology from the same institution.